Background Triaxial accelerometer output [vector magnitude (VM) counts] may better estimate physical activity intensity as reflected in the rate of oxygen uptake (V ˙O2 ) than the traditional vertical axis (VA) counts in adults with Down syndrome (DS). This study examined the accuracy of VM vs. VA counts in estimating V ˙O2 in adults with and without DS across different physical activities and sedentary behaviours. Methods Sixteen adults with DS (10 men and 6 women; 31 ± 15 years) and 19 adults without DS (10 men and 9 women; 24 ± 5 years) performed 12 tasks. V ˙O2 was measured by portable spirometer (K4b 2 , Cosmed) and VM and VA with an accelerometer (wGT3X-BT, Actigraph). Results Vector magnitude and VA were significant predictors of V ˙O2 in adults with DS (P < 0.001; R 2 = 0.74 and 0.65, respectively) and adults without DS (P < 0.001; P < 0.001; R 2 = 0.75 and 0.61, respectively). Absolute error of prediction was significantly smaller for VM than VA for sitting, playing app, drawing, sweeping, standing and basketball (P ≤ 0.005), but smaller for VA than VM for walking at 0.8 m•s À1 (P = 0.005). Bland-Altman plots for adults with and without DS indicated narrower limits of agreement for VM than VA (À5.57 to 5.57 and À6.44 to 6.44 mL•kg À1 •min À1 ; À6.21 to 6.17 and À7.75 to 7.74 mL•kg À1 •min À1 , respectively). Conclusions Vector magnitude and VA are significant predictors of V ˙O2 in adults with and without DS, yet VM more accurately estimated V ˙O2 than VA for most tasks. Development of accelerometer-based prediction of physical activity levels in adults with and without DS may improve by utilising VM counts.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.